This paper presents a new paradigm for distribution system operation in the presence of distributed generation (DG) sources taking into consideration the goodness factor of the DG units. The proposed concept of goodness factor of DG units is based on the computation of the incremental contribution of a DG unit to distribution system losses. The incremental contributions of a DG unit to active and reactive power losses in the distribution system are termed as the active/reactive incremental loss indices (ILI). The goodness factors are integrated directly into the distribution system operations model, which is based on an optimal power flow (OPF) framework. This model seeks to minimize the distribution company's (disco's) energy costs in the short term taking into account the contribution (goodness factor) of each DG unit. Two scenarios are considered in the paper: the first scenario considers the disco to be the owner of the DG units and hence is responsible for their scheduling and dispatch, and the second scenario considers the DG units to be investor-owned. The analysis was carried out considering an 18-bus distribution network extracted from the well-known IEEE 30-bus system and a 69-bus distribution system.
Index Terms-Disco operation, distributed generation, goodness factors, incremental loss index.
Myelodysplastic syndromes (MDS) comprise a group of heterogeneous clonal hematopoietic cell disorders characterized by cytopenias, bone marrow hypercellularity, and increased risk of transformation to acute leukemias. MDS usually transformed to acute myeloid leukemia, and transformation to acute lymphoblastic leukemia (ALL) is rare. Herein, we report a unique patient who presented with MDS with myelofibrosis. Two months after the initial diagnosis, she progressed to a precursor B-cell acute lymphoblastic leukemia. She was treated with induction therapy followed by allogenic stem cell transplantation. She was alive and doing well upon last followup. We have also reviewed the literature and discussed the clinicopathologic features of 36 MDS patients who progressed to ALL reported in the literature.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.